To explore this possibility in PDA, we evaluated selective inhibition of the DEAD-box RNA helicase, eIF4A, using the rocaglate, CR-31 (Supplementary Fig. 1c)16. This evidence concerns the gene EIF4A1 and Patent ductus arteriosus.